We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

FFAI:NASDAQFaraday Future Intelligent Electric Inc. Analysis

Data as of 2026-08-14 - not real-time

$4.68

Latest Price

9/10Risk

Risk Level: High

Executive Summary

Faraday Future Intelligent Electric Inc. trades at $4.68, with its short-term moving averages stacked above the longer-term ones — a bullish trend structure. It has gained 1926.0% over the past 30 days. Momentum indicators put RSI at 57.0 (neutral) with MACD reading bearish. Recent trading has carved out support near $0.1050 and resistance around $14.25.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. Sell-side targets cluster 925.6% above the current quote. Revenue is growing at 62.0%.
The composite risk read is 9/10, putting it in high territory. With 30-day volatility of 1356.0%, a beta of -74.37 and a maximum drawdown of 96.3%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
All three time horizons resolve to hold, carrying 1/10 conviction.

Top Market Events

LOS ANGELES, August 12, 2026--Faraday Future Intelligent Electric Inc.Updated Jul 21, 2026 0 LOS ANGELES-- BUSINESS WIRE --Jul 21, 2026-- Faraday Future Intelligent Electric Inc.LOS ANGELES, August 05, 2026--Faraday Future Intelligent Electric Inc.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 2/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 1.01
  • MACD momentum is negative

Medium Term

1–3 years
Neutral
Model confidence: 1/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 1.01
  • Analyst targets imply +925.6% versus the current price

Long Term

> 3 years
Neutral
Model confidence: 1/10

Key Factors

  • Analyst targets imply +925.6% versus the current price
  • Negative return on equity of -539.6%
  • Revenue growth of +62.0%

Key Metrics & Analysis

Financial Health

Revenue Growth62.00%
P/E Ratio-3.8
ROE-539.61%
ROA-32.50%
Debt/Equity587.42
P/B Ratio-0.7
Op. Cash Flow$-118753000
Free Cash Flow$-90201128

Technical Analysis

TrendBullish
RSI57.0
Support$0.10
Resistance$14.25
MA 20$4.19
MA 50$1.83
MA 200$1.01
MACDBearish
VolumeDecreasing
Fear & Greed Index95.3

Valuation

Target Price$48.00
Upside/Downside925.64%
GradeFair
TypeGrowth

Risk Assessment

Beta-74.37
Volatility1356.00%
Sector RiskHigh
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.